---
$id: https://graph.org.ai/products/commodity/51161716
$type: Product
source: UNSPSC
code: "51161716"
title: "Doxapram"
class: "51161700"
classTitle: "Drugs used for respiratory tract disorders"
family: "51160000"
familyTitle: "Drugs affecting the respiratory tract"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Doxapram

**UNSPSC Code**: 51161716
**Class**: [Drugs used for respiratory tract disorders](Drugs used for respiratory tract disorders.mdx)
**Family**: [Drugs affecting the respiratory tract](../Drugs affecting the respiratory tract.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a cns stimulant with the molecular formula C24H30N2O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 94F3830Q73, chemically known as 2-pyrrolidinone, 1-ethyl-4- (2-morpholinoethyl)-3,3-diphenyl-, monohydrochloride but generally known as doxapram, which bears US NIH Compound Identifier 3156. European Medicines Agency schedules Doxapram in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06382MIG. The term DOXAPRAM is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 19 1975, List 5). World Health Organization schedules doxapram in its Anatomical Therapeutic Chemical (ATC) Classification. DOXAPRAM is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule doxapram under HS 29349990 and SITC 51579. As of Q4 2014, DOXAPRAM remains the US FDA Preferred Term for this commodity. Doxapram bears US NLM identifiers UMLS ID C0013084 and NCI Concept Code C61736. SMILES: O=C1N(CC(C1(C1CCCCC1)C1CCCCC1)CCN1CCOCC1)CC.

